Finance

Lists
002038:SHE
Beijing SL Pharmaceutical Co Ltd
CNÂ¥5.29
-0.75%
(-0.040) 1D
Oct 16, 3:04:36 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002038...
Open
CNÂ¥5.37
High
CNÂ¥5.53
Low
CNÂ¥5.22
Mkt. cap
5.66B
Avg. vol.
25.02M
Volume
25.84M
Dividend
0.19%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 22, 2026
52-wk high
CNÂ¥9.40
52-wk low
CNÂ¥4.81
EPS
-CNÂ¥0.70
Shares outstanding
1.03B
No. of employees
901
Open
CNÂ¥5.37
High
CNÂ¥5.53
Low
CNÂ¥5.22
Mkt. cap
5.66B
Avg. vol.
25.02M
Volume
25.84M
Dividend
0.19%
Quarterly dividend
CNÂ¥0.00
Ex-dividend date
Jul 22, 2026
52-wk high
CNÂ¥9.40
52-wk low
CNÂ¥4.81
EPS
-CNÂ¥0.70
Shares outstanding
1.03B
No. of employees
901
News stories
From web sources and news partners
About Beijing SL Pharmaceutical Co Ltd
CEO-
Employees901
FoundedDec 24, 1994
Headquarters-
SectorBiotechnology
Websiteslpharm.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
153.89M
164.89M
136.84M
114.64M
Cost of goods sold
62.56M
60.70M
49.79M
48.90M
Cost of revenue
62.56M
60.70M
49.79M
48.90M
Research and development expenses
22.44M
40.29M
7.87M
29.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
67.11M
83.75M
43.79M
64.82M
Operating expense
89.08M
129.81M
50.41M
100.99M
Total operating expenses
151.64M
190.51M
100.20M
149.90M
Operating income
2.26M
-25.61M
36.64M
-35.26M
Other non operating income
173.05K
-617.38M
-475.43K
447.02K
EBT including unusual items
22.60M
-437.00M
-103.79M
-193.68M
EBT excluding unusual items
4.81M
-640.58M
36.96M
-27.63M
Income tax expense
2.59M
51.84M
-16.52M
-25.15M
Effective tax rate
11.47%
-11.86%
15.92%
12.98%
Other operating expenses
-1.03M
2.71M
-1.03M
3.25M
Net income
20.05M
-488.30M
-86.11M
-168.96M
Net profit margin
13.03%
-296.13%
-62.93%
-147.39%
Earnings per share
-
-
-
-
Interest and investment income
2.95M
2.22M
795.24K
8.21M
Interest expense
-
-
-
-
Net interest expenses
2.95M
2.22M
795.24K
8.21M
Depreciation and amortization charges
-
-
-
-
EBITDA
40.49M
16.08M
78.33M
6.42M
Gain or loss from assets sale
403.00
46.02K
-
5.85K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps